Enua
Enua Pharma GmbH is a German medical cannabis wholesale distributor that imports EU-GMP certified cannabis flowers from Canadian cultivators and distributes them to over 1,000 partner pharmacies across Germany, with planned UK and Poland expansion in 2026.
- Company typePrivate
- Founded2018
- HeadquartersAachen, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Enua does
Enua Pharma GmbH is a German medical cannabis wholesale distributor headquartered in Cologne (legally registered in Aachen), founded in 2018 originally as Cannify. The company imports EU-GMP certified cannabis flowers from four named Canadian cultivators — AG Medica (Chatham, Ontario), AtlantiCann Medical Inc. (Nova Scotia), Pure Sunfarms (British Columbia), and Safari Flower (Niagara region) — and distributes them through a network of over 1,000 partner pharmacies across Germany. Enua supplements imports with proprietary strain development, expanding its portfolio from 7 to 30 in-house strains alongside a broader catalog of over 100 strains across multiple price segments.
The company's core technology is curation and quality assurance rather than software: all supplier facilities are personally vetted by Enua's quality management and product team and certified by the Cologne Bezirksregierung. Distribution is multi-channel — partner pharmacy network, direct sales/account management, a B2B e-commerce shop for pharmacies and doctors, and a telemedicine pathway integrating platforms such as Flowzz, Weed, Quick-Green, Bloomwell, and DrAnsay — supported by physician training programs and educational content marketing. Pricing for end patients starts at under €10/gram; B2B pricing is handled through the shop and direct relationships.
Enua generates revenue through unit B2B sales of medical cannabis flowers to pharmacies, with end patients reached either directly (online and brick-and-mortar pharmacy dispensing) or via telemedicine-fulfilled prescriptions. The company scaled from €20M+ revenue in 2024 (300%+ YoY growth) to €50M+ in 2025 (2.4x growth), targeting approximately €100M for 2025. Monthly sales volume grew from 250 kg in January 2024 to over 1 tonne by December 2024, and December 2024 alone generated approximately €4.3M. The company maintains double-digit EBITDA margins and in February 2026 secured €25M in debt financing from Deutsche Bank — the largest bank-backed deal in the German cannabis industry — to fund UK (Q1 2026) and Poland (end of 2026) market entry and to participate in expected German market consolidation.
Enua firmographics
Firmographics- Name
- Enua
- Legal name
- ENUA Pharma GmbH
- Website
- https://enua.de
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Enua Pharma GmbH is a German medical cannabis wholesale distributor that imports EU-GMP certified cannabis flowers from Canadian cultivators and distributes them to over 1,000 partner pharmacies across Germany, with planned UK and Poland expansion in 2026.
- Ownership category
- akta.pro rank
Enua industry classification
Industry- Product category
- Medical Cannabis Wholesale
- NAICS
- Health and Personal Care Retailers (456), Pharmacies and Drug Retailers (456110)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Medical Cannabis Dispensaries (CRANAFAB)
- akta.pro secondary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
Keywords
Where Enua is headquartered
LocationHeadquarters
- HQ city
- Aachen
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Enua business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Cannabis Product Sales: Enua generates revenue through the sale of medical cannabis products (dried flower buds) to partner pharmacies across Germany. Products are sold in various price segments with over 100 strains available. The company maintains a B2B e-commerce shop for pharmacy and doctor orders.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Broad product portfolio across multiple price segments |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Enua product offering
Product offeringCore offering
Enua (ENUA Pharma GmbH) is a German medical cannabis wholesale company that distributes EU-GMP certified cannabis flower products sourced from Canadian growers through a network of over 1,000 partner pharmacies in Germany. The company develops its own proprietary cannabis genetics (30 strains, up from 7) and sells to pharmacies and doctors via a B2B e-commerce shop and direct account management, with prescriptions facilitated through partner telemedicine platforms.
Product overview
Enua Pharma GmbH is a German medical cannabis company operating as a single-product platform with supplementary service modules. The core offering is certified medical cannabis flowers sourced from Canadian EU-GMP certified growers (AG Medica, AtlantiCann, Pure Sunfarms, Safari Flower), distributed through a B2B e-commerce platform to a network of over 1,000 partner pharmacies. The product portfolio has expanded from 7 to 30 proprietary cannabis strains, with popular varieties including Jet Fuel Gelato and Pink Kush. Supplementary offerings include a B2B shop with product certificates and educational materials, a medical cannabis brochure for pharmacists, and a newsletter service. The company is transitioning from a medical-only focus toward a broader market approach as German recreational cannabis legalization progresses.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Cannabis Flowers EU-GMP certified pharmaceutical-grade cannabis flowers distributed across multiple price segments (over 100 strains total) for therapeutic prescription use in Germany. Products are sourced from EU-GMP certified Canadian growers (AG Medica, AtlantiCann, Pure Sunfarms, Safari Flower) and dispensed to patients via partner pharmacies after prescription.
- B2B E-commerce Shop Dedicated online ordering platform for pharmacies and doctors to purchase medical cannabis products, with transparent product information, certificates, downloadable templates, and product details.
Quantifiable outcome
- 2.4x revenue growth in 2025 vs 2024, reaching €50M+ in sales
- +2 more outcomes
Companies that use Enua
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Enua technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature3 records
Enua partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- AG MedicacoreCanadian cannabis cultivator based in Chatham, Ontario. State-of-the-art production facility with three-story vertically integrated growing rooms. GACP and GMP certified, with focus on sustainability and water/CO2 reduction. Certified by the Cologne district government on behalf of Enua.
- AtlantiCann Medical Inc. (AMI)coreCanadian cultivator in Nova Scotia with purpose-built facility integrating modern technologies and strictest quality/control standards. EU-GMP and ICANN G.A.P. certified. Produces both modern craft flowers and legacy cultivars, with in-house genetics laboratory for phenotyping and breeding initiatives.
- Pure SunfarmscoreCanadian grower near Vancouver, British Columbia, operating high-tech greenhouses that continue British Columbia's tradition of high-quality cannabis cultivation. Known for Canada's most popular cannabis strains. Certified by the Cologne district government on behalf of Enua.
- Safari FlowercoreCanadian cannabis cultivator from the Niagara region, focusing on quality over speed. Produces craft cannabis flowers with emphasis on quality cultivation practices.
- Spital-Apotheke (Johann Matz)minorHospital pharmacy that combines centuries of pharmaceutical care with modern therapy. Works closely with Enua for stable supply chains, reliable quality, and clear processes for patient safety and continuous therapy continuity.
- Telemedicine Platforms (Flowzz, Weed, Quick-Green, Bloomwell, DrAnsay, Cannabis Ärzte)minorTelemedicine platforms that connect patients with doctors for cannabis prescriptions, enabling Enua's products to reach patients through partner pharmacies after telemedicine consultation.
Scale indicators10 records
Recent moves7 records
Expansion highlights7 records
Enua competitors and assessment
Company assessmentDirect peers
- Cantourage: Berlin-based medical cannabis distributor importing EU-GMP cannabis into Germany and distributing through pharmacies. Direct competitor to Enua with a similar B2B wholesale model.
- Cansativa: German cannabis distribution platform supplying medical cannabis to pharmacies. Direct competitor to Enua in the B2B pharmacy wholesale channel.
- Demecan: German medical cannabis producer and distributor with domestic cultivation and pharmacy distribution. Comparable to Enua's pharmacy-channel strategy with the addition of in-house cultivation.
- Four 20 Pharma: German medical cannabis company focused on import and pharmacy distribution. Competes directly with Enua for pharmacy shelf-space in Germany.
- Nimbus Health: German medical cannabis distributor focused on pharmacy channels. Comparable B2B wholesale model targeting the same customer base as Enua.
Broad incumbents
- Aphria/Tilray Medical: Global cannabis company supplying EU-GMP medical cannabis to German pharmacies. Competes with Enua's imported-product portfolio at much larger scale and broader geographic footprint.
- Aurora Cannabis: Canadian medical cannabis producer with significant EU-GMP production and German distribution. A potential upstream supplier competitor to Enua.
- Canopy Growth: Global cannabis operator with EU-GMP production and German medical market presence. Indirect competitor at the import-source end of Enua's value chain.
Emerging players
- Sanity Group: Berlin-based cannabis company spanning medical and consumer segments. Overlapping with Enua in medical cannabis distribution with a broader adult-use pivot.
- Bloomwell Group: German cannabis platform combining telemedicine, pharmacy distribution, and B2C e-commerce. Overlaps with Enua both as a distribution competitor and as a partner channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Enua social profiles
Digital presenceEnua compliance and trust
Trust signalCompliance4 records
Enua financial estimates
Financial estimateRevenue estimate
Valuation estimate
Enua leadership team
Management profileNumber of profiles
Profiles1 record
Enua funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Enua M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Enua
What does Enua do?
Enua (ENUA Pharma GmbH) is a German medical cannabis wholesale company that distributes EU-GMP certified cannabis flower products sourced from Canadian growers through a network of over 1,000 partner pharmacies in Germany. The company develops its own proprietary cannabis genetics (30 strains, up from 7) and sells to pharmacies and doctors via a B2B e-commerce shop and direct account management, with prescriptions facilitated through partner telemedicine platforms.
Is Enua a public or private company?
Enua is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Enua founded?
Enua was founded in 2018. It employs 51 to 100 people.
Where is Enua based?
Enua is headquartered in Aachen, Germany, in the Europe region.
How does Enua make money?
One revenue line is on record: medical Cannabis Product Sales.
Who are Enua's main competitors?
Direct peers on record are Cantourage, Cansativa, Demecan, Four 20 Pharma and Nimbus Health. Broad incumbents are Aphria/Tilray Medical, Aurora Cannabis and Canopy Growth. Emerging players are Sanity Group and Bloomwell Group.
Does Enua have an API?
No public API is recorded for Enua.
What industry is Enua in?
Enua's product category is Medical Cannabis Wholesale. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 456 and its SIC code is 5122.